Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Novo Nordisk A/S
Age
3–17
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Diagnosis of short stature (height maximum 2 standard deviations of mean for age and gender) or inadequate growth deemed secondary to growth hormone deficiency (GHD)
Naïve to growth hormone therapy
You may not be if
Known or suspected allergy to the trial product or related products
Growth retardation attributable to causes other than GHD. Growth retardation attributable to diabetes mellitus, inborn errors of metabolism, primary bone disease, chromosomal disorders or disease of the genitourinary, cardiopulmonary, gastrointestinal or central nervous system; bone marrow transplantation or any syndrome known to give short stature (examples are: Prader-Willi Syndrome, Russell-Silver Syndrome, Turner Syndrome, Noonan Syndrome)
Intrauterine growth retardation: birth weight below 3rd percentile, adjusted for gestational age
Pregnancy or the intention to become pregnant
Breast-feeding
Administration of other growth-altering medication
Clareo Health | Safety and Efficacy of Somatropin in Children With Growth Hormone Deficiency
